Cargando…
Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?
The dramatic increase in both the number of novel infectious agents and resistance to antimicrobial drugs has incited the need for adjunct therapies in the war against infectious diseases. Exciting recent studies have demonstrated the use of antibodies in the form of intravenous immunoglobulin (IVIg...
Autores principales: | Bayry, Jagadeesh, Lacroix-Desmazes, Sébastien, Kazatchkine, Michel D, Kaveri, Srini V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127229/ https://www.ncbi.nlm.nih.gov/pubmed/15165745 http://dx.doi.org/10.1016/j.tips.2004.04.002 |
Ejemplares similares
-
Therapeutic normal IgG intravenous immunoglobulin activates Wnt-β-catenin pathway in dendritic cells
por: Karnam, Anupama, et al.
Publicado: (2020) -
Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
por: Galeotti, Caroline, et al.
Publicado: (2020) -
Autoimmunity as a Predisposition for Infectious Diseases
por: Maddur, Mohan S., et al.
Publicado: (2010) -
Affinity-Purified Respiratory Syncytial Virus Antibodies from Intravenous Immunoglobulin Exert Potent Antibody-Dependent Cellular Cytotoxicity
por: Gupta, Nimesh, et al.
Publicado: (2013) -
Intravenous Immunoglobulin Therapy Eliminates Candida
albicans and Maintains Intestinal Homeostasis in a Murine Model of Dextran Sulfate Sodium-Induced Colitis
por: Charlet, Rogatien, et al.
Publicado: (2019)